(61 days)
Indications for use include electrosurgical coagulation, dissection, and grasping of tissue during the performance of laparoscopic and general surgical procedures.
The ArtiSential Laparoscopic Instruments – Electrodes, Bipolar series(four versions, ABF01 series, ABD01 series, ABD02 series and ABD04 series) are sterile, single-use, invasive instruments that used in laparoscopic surgery. There are four versions, ABF01 series, ABD01 series, ABD02 series and ABD04 series. Three versions are same except for jaw shape. This product is a specific component, but not the entire electrosurgical device. The device is not intended to be marketed with multiple components, accessories, and as part of a system.
The LivsMed Inc. ArtiSential Laparoscopic Instruments-Electrodes, Bipolar series (four versions) underwent a series of performance tests to demonstrate its safety and effectiveness.
Here's an overview of the acceptance criteria and study details:
1. Acceptance Criteria and Reported Device Performance
| Test Clause and Specification | Test Requirement | Reported Device Performance and Remarks |
|---|---|---|
| 1. Appearance | There should be no defects in the appearance of the product and there should be no problem in use. | No crack, stain, or no substances on the surface of the product. |
| 2. Dimension | It shall be within ± 5% of the indicated value of the dimensional term. | Pass. Refer to [Test result] on pages 9-50 at attachment 12. |
| 3. Operational test | The jaw must be smoothly opened and closed and free from jamming, the jaw and hub can be bent up, down, left, and right a range of above ± 80° and are capable of 360° rotation. | The jaw and hub are bent up, down, left and right within above 80° and can rotate 360°. |
| 4. Tensile strength | The jaw and shaft connections shall not be damaged from pulling of 20 N. | No damage to the connection when applying a force of 20N. |
| 5. Feedthrough test | Electricity should be transmitted between the electrode tip and the connector. | The resistance value between the electrode tip and the connector is less than 1Ω. |
| Biocompatibility (Evaluated according to ISO 10993-1 for Cytotoxicity, Intracutaneous Reactivity, Skin Sensitization, Acute Systemic Toxicity, Pyrogenicity) | The device should demonstrate biological safety for its intended use. | The device has been evaluated for its biological safety, and all specified endpoints (Cytotoxicity, Intracutaneous reactivity, Skin Sensitization, Acute systemic toxicity, Pyrogenicity) were assessed. The document doesn't explicitly state "passed" for biocompatibility but implies successful evaluation as a prerequisite for submission. |
| Electrical Safety (Tested according to IEC 60601-1, IEC 60601-1-2, IEC 60601-1-6, IEC 60601-2-18, and IEC 60601-2-2) | The device should meet the safety requirements for electrosurgical devices. | The device had passed all performed tests. |
| Sterilization (EO-sterilization in accordance with ISO-11135) | The device should be provided sterile and maintain sterility during its shelf life. | The device is provided sterile via EO-sterilization in accordance with ISO-11135. |
| Shelf Life | The device should maintain its performance and sterility for the proposed expiration date. | The proposed expiration date is 3 years from the manufacturing date. Real-time testing will be performed to confirm. |
| Thermal Effect (Histological analysis to porcine tissues: liver, kidney, abdominal muscle) | The electrosurgical device should demonstrate appropriate thermal effects on tissue, without causing excessive or unintended damage, consistent with its intended use for coagulation and dissection. | A histological analysis was performed on thermal effect to porcine tissues (liver, kidney and abdominal muscle) through an electrosurgical device. The document states that the results "demonstrate that the performance requirements were met, the device performs as intended and that the subject device has substantially equivalent performance characteristics to the predicate devices." |
2. Sample Size Used for the Test Set and Data Provenance
The document does not explicitly state the specific sample sizes for each test within the performance data section (e.g., how many devices were tested for dimensions, tensile strength, etc.). However, the tests are laboratory-based and involve physical and electrical characterization of the device.
- Provenance: This is a premarket notification (510(k)) for a medical device. The tests described are laboratory studies conducted by the manufacturer, LivsMed Inc., based in the Republic of Korea. Therefore, the data provenance is likely from laboratory testing conducted in South Korea. The studies are prospective in the sense that they are conducted specifically to demonstrate the device's conformance to standards and claims for regulatory submission.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications
Since this is a physical medical device (laparoscopic instruments-electrodes) and the performance data primarily relates to physical, mechanical, and electrical characteristics, there is no mention of experts establishing a "ground truth" for a test set in the traditional sense of diagnostic accuracy studies. The "ground truth" for these tests is defined by the established engineering specifications, international standards (e.g., IEC, ISO), and performance requirements for electrosurgical instruments.
For the thermal effect study, histological analysis was performed. This would implicitly involve qualified personnel (e.g., pathologists or histotechnicians) to interpret the tissue samples, but the document does not specify their number or qualifications.
4. Adjudication Method for the Test Set
Not applicable. The tests are directly measuring physical and electrical properties against predefined numerical or qualitative criteria. This is not a scenario that typically requires an adjudication method as seen in diagnostic image interpretation.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done
No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done. This type of study is relevant for diagnostic devices (e.g., AI in radiology) where human readers interpret cases. The device in question is a surgical instrument.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
No, a standalone (algorithm only) performance study was not done. This device is a manual surgical instrument, not an AI algorithm.
7. The Type of Ground Truth Used
The "ground truth" for these performance tests is based on:
- Engineering specifications and design requirements: For appearance, dimension, operational tests (jaw movement, rotation), and tensile strength.
- International standards: For biocompatibility (ISO 10993-1), electrical safety (IEC 60601 series), and sterilization (ISO-11135).
- Physical laws/principles: For feedthrough (electrical resistance).
- Histological analysis: For thermal effects, where the "ground truth" would be the observed tissue changes interpreted by qualified personnel against expected outcomes for electrosurgical devices.
8. The Sample Size for the Training Set
Not applicable. This device is a physical instrument, not an AI/ML algorithm. Therefore, there is no "training set" in the context of machine learning.
9. How the Ground Truth for the Training Set Was Established
Not applicable, as there is no training set.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
April 26, 2023
LivsMed Inc. Dong Wook Lee QMR (Quality Management Representative) #304, D-dong, 700, Pangyo-ro, Bundang-gu Seongnam-si. Gyeonggi-do 13516 Korea, South
Re: K230499
Trade/Device Name: ArtiSential Laparoscopic Instruments-Electrodes, Bipolar series (four versions, ABF01series, ABD01 series, ABD02 series and ABD04 series)
Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: Class II Product Code: GEI Dated: February 24, 2023 Received: February 24, 2023
Dear Dong Lee:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Mark Trumbore, Ph.D. Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Image /page/2/Picture/0 description: The image shows the logo for LIV'SMED. The logo is in a dark blue color, with the apostrophe in LIV'SMED being a lighter blue color. The font is sans-serif and the letters are all capitalized.
3. Indications for Use Statement
{3}------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known) K230499
Device Name
ArtiSential Laparoscopic Instruments-Electrodes, Bipolar series (four versions, ABF01 series, ABD02 series and ABD04 series)
Indications for Use (Describe)
Indications for use include electrosurgical coagulation, dissection, and grasping of tissue during the performance of laparoscopic and general surgical procedures.
| Type of Use (Select one or both, as applicable) | Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) |
|---|---|
| ------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB number."
{4}------------------------------------------------
510(k) Summary
1. General Information
| Applicant/Submitter: LivsMed Inc. | |
|---|---|
| Address: | #304, D-dong, 700, Pangyo-ro, Bundang-gu, 13516Seongnam-si, Gyeonggi-do, Republic of KoreaTel) +82-70-4282-7652Fax) +82-31-706-3211 |
| Contact Person: | Dong Wook Lee / QMR(Quality Management Representative) |
| Address: | #304, D-dong, 700, Pangyo-ro, Bundang-gu, 13516Seongnam-si, Gyeonggi-do, Republic of KoreaTel) +82-70-7709-4993Fax) +82-31-706-3211Email) dongwook.livsmed@gmail.com |
| Preparation Date: | 02-24-2023 |
2. Device Name and Code
| Device Trade Name | ArtiSential Laparoscopic Instruments-Electrodes,Bipolar Series (four versions, ABF01 series, ABD01series, ABD02 series and ABD04 series) |
|---|---|
| Common Name | Electrosurgical Instruments |
| Classification Name | Electrosurgical, cutting & coagulation & accessories |
| Product Code | GEI |
| Regulation Number | 21 CFR 878.4400 |
| Classification | Class II |
| Review Panel | General & Plastic Surgery |
3. Predicate Devices
ArtiSential Laparoscopic Instruments-Electrodes, Bipolar Series(four versions, ABF01 series, ABD01 series, ABD02 series and ABD04 series) are substantially equivalent to the following devices
{5}------------------------------------------------
Table 3.1 Predicate device 1
| Applicant | Device Name | 510(k) Number |
|---|---|---|
| LivsMed Inc. | ArtiSential BipolarFenestrated Forceps | K200875 |
Table 3.2 Predicate device 2
| Applicant | Device Name | 510(k) Number |
|---|---|---|
| LivsMed Inc. | ArtiSential BipolarFenestrated Forceps | K220384 |
4. Device Description
The ArtiSential Laparoscopic Instruments – Electrodes, Bipolar series(four versions, ABF01 series, ABD01 series, ABD02 series and ABD04 series) are sterile, single-use, invasive instruments that used in laparoscopic surgery. There are four versions, ABF01 series, ABD01 series, ABD02 series and ABD04 series. Three versions are same except for jaw shape. This product is a specific component, but not the entire electrosurgical device. The device is not intended to be marketed with multiple components, accessories, and as part of a system.
5. Indications for use
- 5.1 Indications for use
Indications for use include electrosurgical coagulation, dissection, and grasping of tissue during the performance of laparoscopic and general surgical procedures.
6. Technical Characteristics in Comparison to Predicate Devices
| Proposed device | Predicate Device 1 | Predicate Device 2 | |
|---|---|---|---|
| 510(K)Number | In process | K200875 | K220384 |
| Manufacture | LivsMed, Inc. | LivsMed, Inc. | LivsMed, Inc. |
| Device Name | ArtiSential LaparoscopicInstruments-Electrodes | ArtiSential LaparoscopicInstruments-Electrodes | ArtiSential LaparoscopicInstruments-Electrodes |
| Clearance Date | N/A | 05-21-2020 | 02-24-2022 |
| Classification /Regulation | Class 2 / 878.4400 | Class 2 / 878.4400 | Class 2 / 878.4400 |
| Product Code | GEI | GEI | GEI |
| Intended for | Prescription Use | Prescription Use | Prescription Use |
| Indications forUse | Electrosurgicalcoagulation, dissection,and grasping of tissueduring the performanceof laparoscopic andgeneral surgicalprocedures. | Electrosurgicalcoagulation, dissection,and grasping of tissueduring the performanceof laparoscopic andgeneral surgicalprocedures. | Electrosurgicalcoagulation, dissection,and grasping of tissueduring the performanceof laparoscopic andgeneral surgicalprocedures. |
| Principles of | This product is a single- | This product is a single- | This product is a single- |
| operation | use instrument used in | use instrument used in | use instrument used in |
| electrosurgical units to | electrosurgical units to | electrosurgical units to | |
| hold soft tissues or | hold soft tissues or | hold soft tissues or | |
| coagulate and make an | coagulate and make an | coagulate and make an | |
| incision (tissue | incision (tissue | incision (tissue | |
| dissection) during | dissection) during | dissection) during | |
| general laparoscopic | general laparoscopic | general laparoscopic | |
| surgery, which uses the | surgery, which uses the | surgery, which uses the | |
| principle of applying | principle of applying | principle of applying | |
| high-frequency currents | high-frequency currents | high-frequency currents | |
| from the electrode to the | from the electrode to the | from the electrode to the | |
| human body to generate | human body to generate | human body to generate | |
| heat by bioimpedance | heat by bioimpedance | heat by bioimpedance | |
| when radio frequency | when radio frequency | when radio frequency | |
| (RF) energy from the | (RF) energy from the | (RF) energy from the | |
| electrosurgical unit | electrosurgical unit | electrosurgical unit | |
| applies an electric | applies an electric | applies an electric | |
| current to the electrode | current to the electrode | current to the electrode | |
| part, and using the | part, and using the | part, and using the | |
| generated heat to incise | generated heat to incise | generated heat to incise | |
| cellular tissues and cause | cellular tissues and cause | cellular tissues and cause | |
| coagulation. | coagulation. | coagulation. | |
| It is composed of a jaw, | It is composed of a jaw, | It is composed of a jaw, | |
| Φ8 diameter shaft, grip | Φ8 diameter shaft, grip | Φ8 diameter shaft, grip | |
| (including a control | (including a control | (including a control | |
| ring), and electrosurgical | ring), and electrosurgical | ring), and electrosurgical | |
| unit connection | unit connection | unit connection | |
| electrode connector. | electrode connector. | electrode connector. | |
| During a procedure with | During a procedure with | During a procedure with | |
| this product, the jaw | this product, the jaw | this product, the jaw | |
| opens if the control ring | opens if the control ring | opens if the control ring | |
| opens, and jaw closes if | opens, and jaw closes if | opens, and jaw closes if | |
| the control ring closes. | the control ring closes. | the control ring closes. | |
| In addition, the jaw is | In addition, the jaw is | In addition, the jaw is | |
| also bent up, down, left | also bent up, down, left | also bent up, down, left | |
| and right within a range | and right within a range | and right within a range | |
| of ±80° or more by | of ±80° or more by | of ±80° or more by | |
| moving the grip up, | moving the grip up, | moving the grip up, | |
| down, left and right, andthe jaw can also turn | down, left and right, andthe jaw can also turn | down, left and right, andthe jaw can also turn | |
| 360° when rotating the | 360° when rotating the | 360° when rotating the | |
| grip. | grip. | grip. | |
| Energy Type | Radiofrequency | Radiofrequency | Radiofrequency |
| Electrode type | Bipolar | Bipolar | Bipolar |
| (monopolar or | |||
| bipolar) | |||
| Physical | - Shaft diameter: 8mm | - Shaft diameter: 8mm | - Shaft diameter: 8mm |
| dimensions | - Shaft Length: 250mm, | - Shaft Length: 250mm, | - Shaft Length: 250mm, |
| and design | 380mm, 450mm | 380mm, 450mm | 380mm, 450mm |
| (size, length) | |||
| Rated voltage | 200Vp | 200Vp | 200Vp |
| Materials | Stainless steel | Stainless steel | Stainless steel |
| (electrode) | |||
| Materials(insulation) | Polyetherimide | Polyetherimide | Polyetherimide |
| Materials(Shaft) | Glass fiber | Glass fiber | Glass fiber |
| Articulatingfeature | Pitch:±80° or more,Yaw:±80° or more andOpen-Close | Pitch:±80° or more,Yaw:±80° or more andOpen-Close | Pitch:±80° or more,Yaw:±80° or more andOpen-Close |
| Tip rotation | 360° | 360° | 360° |
| Sterilization | EO | EO | EO |
Table 6.1 Predicate Device
{6}------------------------------------------------
{7}------------------------------------------------
7. Performance Data
7.1 Biocompatibility
The device has been evaluated for its biological safety according to ISO 10993-1 "Biological Evaluation of Medical Devices – Part 1 : Evaluation and Testing Within a Risk Management Process". Following endpoints have been assessed during the evaluation:
- Cytotoxicity -
- -Intracutaneous reactivity
- -Skin Sensitization
- Acute systemic toxicity -
- -Pyrogenicity
7.2 Electrical Safety
The ArtiSential Laparoscopic Instruments-Electrodes, Bipolar Series(four versions, ABF01 series, ABD01 series, ABD02 series and ABD04 series) have been tested according to IEC 60601-1, IEC 60601-1-2, IEC 60601-1-6, IEC 60601-2-18 and IEC 60601-2-2. The test setup included:
The device had passed all performed tests.
7.3 Sterilization
ArtiSential Laparoscopic Instruments-Electrodes, Bipolar Series(four versions, ABF01 series. ABD01 series, ABD02 series and ABD04 series) are provided sterile, intended to be single-use. This product is EO-Sterilization in accordance with ISO-11135.
- 7.4 Shelf life
The proposed expiration date is 3 years from the manufacturing date. The real-time testing will be performed to confirm the shelf-life for 3 years
7.5 Performance test
The device had passed all performed tests.
{8}------------------------------------------------
| Test clause and specification | Test requirement | Results- Remarks |
|---|---|---|
| 1. Appearance: Implement the visualinspection for surface of thedevice | There should be no defects inthe appearance of the productand there should be noproblem in use. | No crack, stain or nosubstances on the surfaceof the product |
| 2. Dimension: Measure by ruler and verniercalipers | It shall be within $\pm$ 5% of theindicated value of thedimensional term. | PassRefer to [Test result] on9-50 page at attachment12 |
| 3. Operational test: Manipulating the grip andcontrol ring, and measure theangle at bending and rotationby goniometer. | The jaw must be smoothlyopened and closed and freefrom jamming, the jaw andhub can be bent up, down,left, and right a range ofabove $\pm$ 80° and are capableof 360° rotation. | The jaw and hub are bentup, down, left and rightwithin above 80° and canrotate 360°. |
| 4. Tensile strength: Hold the jaw and shaftconnections respectively andapply a force of 20 N usingPush pull gauge. | The jaw and shaftconnections shall not bedamaged from pulling of 20N. | No damage to theconnection when applyinga force of 20N |
| 5. Feedthrough test: Electrical conductionbetween the electrode tip andthe connector is tested using aDMM (digital multi meter). | Electricity should betransmitted between theelectrode tip and theconnector. | The resistance valuebetween the electrode tipand the connector is lessthan 1Ω |
7.6 Thermal effect
Thermal effects on tissue were also tested. A histological analysis was performed on thermal effect to porcine tissues(liver, kidney and abdominal muscle) through an electrosurgical device.
Based on these performance characteristics, the results demonstrate that the performance requirements were met, the device performs as intended and that the subject device has substantially equivalent performance characteristics to the predicate devices.
8. Substantial Equivalence
ArtiSential Laparoscopic Instruments-Electrodes, Bipolar Series(four versions, ABF01 series, ABD01 series, ABD02 series and ABD04 series) indication for use is same to the predicate device 1 (K200875) and predicate device 2 (K220384). The energy type, electrode type, sterilization as well as physical characteristics are the same. Although there are some minor differences with each product, these differences between the ArtiSential Bipolar Series and the predicate device do not raise new or different questions of safety and efficacy. There is no new technology and no difference that would raise new or different questions of safety or efficacy.
{9}------------------------------------------------
9. Conclusions
In conclusion, the comparison carried out covers all products, models, sizes, and the entire intended purpose of the device under evaluation. The subject device which is the ArtiSential Laparoscopic Instruments-Electrodes, Bipolar Series(four versions, ABF01 series, ABD01 series, ABD02 series and ABD04 series) are same to the predicate device in principles of operation, technological characteristics, as well as performance characteristics. The testing was conducted to evaluate the performance of subject device in comparison to the predicate device. Results of validation and verification activities in design control that include testing/certification to designated standards and performance testing of the devices has demonstrated substantial equivalence of the subject device to the predicate in terms of safety and effectiveness for requested intended use.
§ 878.4400 Electrosurgical cutting and coagulation device and accessories.
(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.